ADVERTISEMENT
India’s bio-economy registered a 9.75% growth, reaching $165.7 billion in 2024, compared to $151.1 billion the previous year. This marks a significant rise from $86 billion in 2020, according to the annual India Bio-Economy Report (IBER) published by the Biotechnology Industry Research Assistance Council (BIRAC), a government body. The growth has been driven by advancements in biotechnology, agricultural innovation, bio-manufacturing, and healthcare, the report notes.
IBER highlights that the bio-industrial and bio-pharma segments were the primary drivers of growth in 2024, collectively accounting for nearly 82.4% of the sector’s value. The bio-industrial segment contributed $78.2 billion, while bio-pharma stood at $58.4 billion. The report also pointed out that although the bio-agricultural segment and bio-IT/research services held smaller shares of 8.1% and 9.4% respectively, they remain crucial for fostering innovation and addressing key challenges in agriculture and healthcare.
July 2025
In the world’s youngest nation—where over 65% of the population is under 35—India’s future is already being shaped by those bold enough to lead it. From boardrooms to breakout ideas, a new generation of business leaders is rewriting the rules. This year's Fortune India’s 40 Under 40 celebrates these changemakers—icons in the making like Akash Ambani, Kaviya Kalanithi Maran, Shashwat Goenka, Parth Jindal, Aman Mehta, and Devansh Jain—who are not just carrying forward legacies but boldly reimagining them for a new era. Alongside them are first-generation disruptors like Sagar Daryani, scaling Wow! Momo with a vision to take ₹100 momos to 5,000 cities, and Palak Shah, turning the Banarasi weave into a global fashion story with Ekaya Banaras. These are the entrepreneurs turning ambition into scale. And even beyond traditional industry, the entrepreneurial wave is pulling in creative forces—Ranveer Singh, for instance, is shaking up wellness and nutrition with Bold Care and SuperYou, proving that passion, backed by purpose, is the new blueprint for building brands.
The bio-industrial segment encompasses bio-based chemicals and products developed using enzymes, biosynthetic processes, and recombinant DNA technology. It includes biofuels, bioplastics, biogas, and enzymatic applications across industries ranging from beverages to detergents. The bio-pharma and bio-medical sectors focus on pharmaceuticals, medical devices, diagnostics, and lab-grown organoids, with advancements in cancer immunotherapy, gene editing, precision medicine, and biologics. Bio-research and bio-IT segments cover contract research, clinical trials, biotech software and databases, specialized equipment, and bioscience education services. Meanwhile, the bio-agriculture sub-segment includes genetically modified crops, precision agriculture, and bio-based products, with Bt cotton serving as a key example of biotech’s role in improving agricultural yields and sustainability.
“Biotechnology is no longer just a sector—it is a pillar of India’s economic growth. The bio-economy now contributes 4.25% to the national GDP ($3.89 trillion). India’s unique challenges require a tailored approach, and BIRAC is playing a crucial role in propelling the country’s biotech sector towards a brighter future,” said Dr. Rajesh S. Gokhale, Secretary, DBT, and Chairman, BIRAC.
According to the report, Maharashtra led India’s bio-economy with a value of $35.45 billion, representing 21.4% of the total bio-economy. Karnataka ($32.37 billion), Telangana ($19.9 billion), Gujarat ($12.9 billion), Uttar Pradesh ($11.3 billion), Andhra Pradesh ($11.1 billion), and Tamil Nadu ($9.9 billion) were also major contributors.
In 2024, 1,544 new biotech startups were incorporated across the country, bringing the total number of biotech startups in India to 10,075.
Fortune India is now on WhatsApp! Get the latest updates from the world of business and economy delivered straight to your phone. Subscribe now.